Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Psychopharmacology Bulletin|December 11, 2002
Clinical significance of drug binding, protein binding, and binding displacement drug interactionsMichael W JannPharmacotherapy|December 9, 2004
Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesisMichael W JannThe American Journal of Managed Care|November 18, 2011
Advanced strategies for treatment of Parkinson's disease: the role of early treatmentMichael W JannAmerican Health & Drug Benefits|January 23, 2015
Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatmentsMichael W JannTransgender Health|July 11, 2019
The Evolving Role of Pharmacists in Transgender Health CareJan S Redfern, Michael W JannCNS Drugs|June 3, 2018
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between AgentsMichael W Jann, Scott R PenzakCNS Drugs|March 24, 2018
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between AgentsMichael W Jann, Scott R PenzakPharmacotherapy|October 30, 2007
Antidepressant agents for the treatment of chronic pain and depressionMichael W Jann, Julian H SladeClinical Pharmacokinetics|August 7, 2002
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitorsMichael W Jann, Kara L Shirley, Gary W SmallAmerican Journal of Pharmaceutical Education|December 14, 2019
An Elective Course in Lesbian, Gay, Bisexual, and Transgender Health and Practice IssuesMichael W Jann, Scott Penzak, Annesha White, et al.Pageof 3